Virtual Meeting
16:3016:50
Lecture under the auspices of Bristol Myers Squibb:
Current approaches in melanoma in metastatic settings
Hanna Koseła-Paterczyk
20 min
16:5017:05
Cellular therapies, bispecific receptors/antibodies, intratumoral therapies Tomasz Świtaj
15 min
17:0517:25
Uveal melanoma — what we should know in 2026? Paweł Rogala
20 min
17:2517:45
Rare skin tumours Alice Indini
20 min
17:4518:10
Lecture sponsored by Pierre Fabre Médicament:
Personalized therapy for advanced BRAF-positive melanoma — importance of BRAF/MEK inhibitors
Anna M. Czarnecka
25 min
18:1018:25
Lecture sponsored by Medison: When advanced uveal melanoma turns challenging: real‑world oncology practice insights Monika Dudzisz-Śledź
15 min
18:2518:45
How to manage rare toxicities Mario Mandala
20 min
18:4518:55
Lecture sponsored by Pierre Fabre Médicament: Interesting cases Katarzyna Kisielewska
10 min
18:5519:05
Interesting cases Vincas Urbonas
10 min
19:0519:20
Discussion
15 min
Copyrights © 2026 Via Medica